Skip to main content
Log in

Analgesic and Immunomodulatory Effects of Codeine and Codeine 6-glucuronide

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The antinociceptive and immunosuppressive effects of codeine and codeine 6-glucuronide were determined in rats after intra-cerebroventricular administration.

Methods. Codeine 6-glucuronide was synthesized using a modification of the Koenigs-Knorr reaction. A lipophilic intermediate formed during synthesis, methyl [codein-6-yl-2,3,4-tri-O-acetyl-β-D-glucopyranosid] uronate, was also tested. Morphine was used as a positive control to compare antinociceptive potencies of these compounds.

Results. All compounds tested produced significant analgesic responses, as assessed by the tail flick model. Additionally, codeine 6-glucuronide showed significantly less immunosuppressive effects than codeine in vitro.

Conclusions. We conclude that codeine 6-glucuronide and related compounds may have clinical benefit in the treatment of pain in immune compromised patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Q. Y. Yue, J. O. Svensson, C. Alm, F. Sjoqvist and J. Sawe. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br. J. Clin. Pharmacol. 28:639–645 (1989).

    Google Scholar 

  2. Z. R. Chen, R. J. Irvine, F. Bochner and A. A. Somogii. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolizers. Br. J. Clin. Pharmacol. 31:381–390 (1991).

    Google Scholar 

  3. K. C. Persson, M. Hammarlund-Udenaes, O. Moritimer and A. Rane. The postoperative pharmacokinetics of codeine. Eur. J. Clin. Pharmacol. 42:663–666 (1992).

    Google Scholar 

  4. W. D. Bechtel and K. Sinterhauf. Plasma level and renal excretion of 3H-codeine in man and in the dog. Arzneim.-Forsch. 28:308–310 (1978).

    Google Scholar 

  5. S. Y. Yeh and L. A. Woods. Physiological disposition of N-14C-methyl codeine in the rat. J. Pharmacol. Exp. Ther. 166:86–95 (1969).

    Google Scholar 

  6. S. Y. Yeh and L. A. Woods. Isolation of morphine-3-glucuronide from urine and bile of rats injected with codeine. J. Pharmacol. Exp. Ther. 175:69–74 (1970).

    Google Scholar 

  7. T. Johannesson and J. Shou. Morphine and normorphine in the brains of rats given identically analgesic doses of morphine, codeine or normorphine. Acta Pharmacol. Toxicol. 20:165–173 (1963).

    Google Scholar 

  8. T. Johannesson and L.A. Woods. Analgesic action and brain and plasma levels of morphine and codeine in morphine tolerant, codeine tolerant and nontolerant rats. Acta Pharmacol. Toxicol. 2:381–396 (1964).

    Google Scholar 

  9. H. Yoshimura, M-A. Mori, K. Oguri and H. Tsukamoto. Metabolism of drugs-LXV. Studies on the urinary conjugated metabolites of codeine. Biochem. Pharmacol. 19:2353–2360 (1970).

    Google Scholar 

  10. K. Oguri, M. Hanioka and H. Yoshimura. Species differences in the metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits. Xenobiotica. 20:683–688 (1990).

    Google Scholar 

  11. A. J. Lawrence, A. Michalkiewicz, J. S. Morley, K. Mackinnon and D. Billington. Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions. Biochem. Pharmacol. 43:2335–2340 (1992).

    Google Scholar 

  12. H. Yoshimura, S. Ida, K. Oguri and H. Tsukamoto. Biochemical basis for analgesic activity of morphine-6-glucuronide—1. Biochem. Pharmacol. 22:1423–1430 (1973).

    Google Scholar 

  13. F. V. Abbott and R. M. Palmour. Morphine-6-glucuronide: analgesic effects and binding profile in rats. Life Sci. 43:1685–1695 (1988).

    Google Scholar 

  14. G. W. Pasternak, S. R. Childers and S. H. Snyder. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors. Science. 208:514–516 (1980).

    Google Scholar 

  15. D. Paul, K. M. Standifer, C. E. Inturrisi and G. W. Pasternak. Pharmacological characterization of morphine-6-glucuronide, a very potent metabolite. J. Pharmacol. Exp. Ther. 251:477–483 (1989).

    Google Scholar 

  16. Q. L. Gong, T. Hedner, J. Hedner, R. Bjorkman and G. Nordberg. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur. J. Pharmacol. 193:47–56 (1991).

    Google Scholar 

  17. Q. L. Gong, G. Nordberg, J. Hedner, R. Bjorkman and T. Hedner. Morphine-3-glucuronide may functionally antagonize the morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain. 48:249–255 (1992).

    Google Scholar 

  18. M. H. Hanna, S. J. Peat, M. Woodham, A. Knibb and C. Fung. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. Br. J. Anaesth. 64:547–550 (1990).

    Google Scholar 

  19. R. Osborne, S. P. Joel, D. Trew and M. Slevin. Analgesic activity of morphine-6-glucuronide. Lancet. i:828 (1988).

    Google Scholar 

  20. R. Osborne, P. Thompson, S. P. Joel, D. Trew, N. Patel and M. Slevin. The analgesic activity of morphine-6-glucuronide. Br. J. Clin. Pharmacol. 34:30–138 (1992).

    Google Scholar 

  21. M. H. Hanna, S. J. Peat, A. Knibb and C. Fung. Disposition of morphine 6-glucuronide and morphine in healthy volunteers. Br. J. Anaesth. 66:103–107 (1991).

    Google Scholar 

  22. M. Barjavel, P. Sandouk, M. Plotkine and J. M. Scherrmann. Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis. Life Sci. 55:1301–1308 (1994).

    Google Scholar 

  23. Y. Shavit, A. Depaulis, F. C. Martin, G. W. Terman, R. N. Pechnick, C. J. Zane, R. P. Gale and J. C. Leibeskind. Involvement of brain opiate receptors in the immunosuppressive effect of morphine. Proc. Natl. Acad. Sci. USA. 83:7114–7117 (1986).

    Google Scholar 

  24. M. C. Hernanadez, L. R. Flores and B. M. Bayer. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267:1336–1341 (1993).

    Google Scholar 

  25. D. B. Louria, T. Hensle and J. Rose. The major medical complications of heroin addiction. Ann. Intern. Med. 67:1–22 (1967).

    Google Scholar 

  26. S. M. Brown, B. Timmel, R. N. Taub, S. Kochwa and R. E. Rosenfeld. Immunological dysfunction in heroin addicts. Arch. Intern. Med. 134:1001–1006 (1974).

    Google Scholar 

  27. C. C. Chao, T. W. Moliter, K. Close, S. Hue and P. K. Peterson. Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int. J. Immunopharmacol. 15:447–453 (1993).

    Google Scholar 

  28. H. Yoshimura, K. Oguri and H. Tsukamoto. Metabolism of drugs LX. The synthesis of codeine and morphine glucuronides. Chem. Pharm. Bull. 16:2114–2119 (1968).

    Google Scholar 

  29. L. A. Berglund and J. W. Simpkins. Alterations in brain opioid receptor mechanisms on proestrous afternoon. Neuroendocrinology. 48:394–400 (1988).

    Google Scholar 

  30. T. B. Vree and C. P. W. Verwey-Vanwissen. Pharmacokinetics and metabolism of codeine in humans. Biopharm. Drug Disp. 13:445–460 (1992).

    Google Scholar 

  31. Q. Y. Yue, J. Hasselstrom, J. O. Svensson and J. Sawe. Pharmacokinetics of codeine and its metabolites in caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine. Br. J. Clin. Pharmacol. 31:635–642 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srinivasan, V., Wielbo, D., Simpkins, J. et al. Analgesic and Immunomodulatory Effects of Codeine and Codeine 6-glucuronide. Pharm Res 13, 296–300 (1996). https://doi.org/10.1023/A:1016059618633

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016059618633

Navigation